Cargando…

Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer

BACKGROUND: Sarcopenia is an important prognostic factor of lung cancer. The serum creatinine/cystatin C ratio (CCR) and the sarcopenia index (SI, serum creatinine × cystatin C‐based glomerular filtration rate) are novel screening tools for sarcopenia; however, the diagnostic accuracy of the CCR and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Tianjiao, Xie, Lingling, Hu, Song, Tan, Lingling, Lei, Xiaozhen, Luo, Xiaozhen, Yang, Ling, Yang, Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178169/ https://www.ncbi.nlm.nih.gov/pubmed/35297568 http://dx.doi.org/10.1002/jcsm.12977

Ejemplares similares

Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients
por: Tang, Tianjiao, et al.
Publicado: (2020)

Diagnostic Value of Serum Creatinine and Cystatin-C-Based Indices and Ishii Score in Cancer-Related Sarcopenia
por: Ding, Liming, et al.
Publicado: (2023)

A sarcopenia index based on serum creatinine and cystatin C cannot accurately detect either low muscle mass or sarcopenia in urban community-dwelling older people
por: He, Qian, et al.
Publicado: (2018)

Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer
por: Zheng, Chao, et al.
Publicado: (2022)

A Novel Application of Serum Creatinine and Cystatin C to Predict Sarcopenia in Advanced CKD
por: Lin, Yu-Li, et al.
Publicado: (2022)

Sarcopenia and myosteatosis diagnostic tool for gastrointestinal cancer: creatinine to cystatin C ratio as evaluation marker
por: Liu, Hao, et al.
Publicado: (2023)

Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer
por: Sun, Jing, et al.
Publicado: (2022)

Sarcopenia Index Based on Serum Creatinine and Cystatin C is Associated with Mortality, Nutritional Risk/Malnutrition and Sarcopenia in Older Patients
por: Ren, Chenxi, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours
por: Ding, Ping’an, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a prognostic indicator for patients with colorectal cancer
por: Gao, Shunhui, et al.
Publicado: (2023)

Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis
por: Fujita, Kohei, et al.
Publicado: (2022)

Serum cystatin C to creatinine ratio is associated with sarcopenia in non-dialysis-dependent chronic kidney disease
por: An, Jung Nam, et al.
Publicado: (2022)

Serum creatinine/cystatin C ratio as a case-finding tool for low handgrip strength in Chinese middle-aged and older adults
por: Tan, Lingling, et al.
Publicado: (2020)

Predictive value of serum creatinine/cystatin C in neurocritically ill patients
por: Wang, Shengnan, et al.
Publicado: (2019)

Inflammatory indexes are not associated with sarcopenia in Chinese community-dwelling older people: a cross-sectional study
por: Tang, Tianjiao, et al.
Publicado: (2020)

Sarcopenia index based on serum creatinine and cystatin C predicts the risk of postoperative complications following hip fracture surgery in older adults
por: Chen, Xiaoyan, et al.
Publicado: (2021)

Factors That Improve Chest Computed Tomography-Defined Sarcopenia Prognosis in Advanced Non-Small Cell Lung Cancer
por: Yang, Ming, et al.
Publicado: (2021)

MON-LB073 The Serum Creatinine to Serum Cystatin C Ratio Is a Reliable Surrogate Marker of Sarcopenia in Patients with Cushing's Syndrome in Remission
por: Martel, Luciana, et al.
Publicado: (2019)

Serum-Creatinine-to-Cystatin C-to-Waist-Circumference Ratios as an Indicator of Severe Airflow Limitation in Older Adults
por: Li, Jinxuan, et al.
Publicado: (2023)

Use of Both Serum Cystatin C and Creatinine as Diagnostic Criteria for Contrast‐Induced Acute Kidney Injury and Its Clinical Implications
por: Zhang, Wei‐feng, et al.
Publicado: (2017)

The serum creatinine to cystatin C ratio predicts the risk of acute exacerbation of chronic obstructive pulmonary disease
por: He, Liang, et al.
Publicado: (2023)

Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease
por: Lin, Yu-Li, et al.
Publicado: (2021)

Serum creatinine to cystatin C ratio and cognitive function among middle-aged and older adults in China
por: Zhu, Yueli, et al.
Publicado: (2022)

Serum Cystatin-C Is Not Superior to Serum Creatinine in Predicting Glomerular Filtration Rate in Cirrhotic Patients
por: Nasseri-Moghaddam, Siavosh, et al.
Publicado: (2013)

Reference intervals for serum cystatin C and serum creatinine in an adult sub-Saharan African population
por: Edinga-Melenge, Bertille Elodie, et al.
Publicado: (2019)

Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Huang, Dan, et al.
Publicado: (2022)

Relationships between cystatin C- and creatinine-based eGFR in Japanese rural community- dwelling older adults with sarcopenia
por: Kusunoki, Hiroshi, et al.
Publicado: (2020)

Creatinine-to-cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifan, et al.
Publicado: (2022)

Estimation of glomerular filtration rate from serum creatinine and cystatin C in octogenarians and nonagenarians
por: Lopes, Marcelo B, et al.
Publicado: (2013)

Utility of serum creatinine/cystatin C ratio in diagnosis of postrenal acute kidney injury
por: İnal, Salih, et al.
Publicado: (2014)

A Systematic Review of the Effect of N-Acetylcysteine on Serum Creatinine and Cystatin C Measurements
por: Huang, Johnny W., et al.
Publicado: (2020)

A New Index Based on Serum Creatinine and Cystatin C Can Predict the Risks of Sarcopenia, Falls and Fractures in Old Patients with Low Bone Mineral Density
por: Ge, Jiaying, et al.
Publicado: (2022)

Serum Cystatin C as a Marker of Renal Function in Critically Ill Patients With Normal Serum Creatinine
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2014)

Correction: Creatinine‑to‑cystatin C ratio as a marker of sarcopenia for identifying osteoporosis in male patients with type 2 diabetes mellitus
por: Dai, Huifang, et al.
Publicado: (2022)

Creatinine and cystatin C: Shooting at a flying target
por: Chao, Chia-Ter
Publicado: (2011)

Serum creatinine/cystatin C ratio as a muscle mass evaluating tool and prognostic indicator for hospitalized patients: A meta-analysis
por: Zheng, Wen-He, et al.
Publicado: (2023)

Relationship Between Serum Cystatin C and Creatinine or Dialysis Adequacy in Patients on Chronic Maintenance Hemodialysis
por: Khorgami, Zhinoos, et al.
Publicado: (2013)

Serum Creatinine-to-Cystatin C Ratio in the Progression Monitoring of Non-alcoholic Fatty Liver Disease
por: Li, Shaobo, et al.
Publicado: (2021)

Performance and Determinants of Serum Creatinine and Cystatin C–Based GFR Estimating Equations in South Asians
por: Wang, Yeli, et al.
Publicado: (2021)

Estimating Glomerular Filtration Rate from Serum Myo-Inositol, Valine, Creatinine and Cystatin C
por: Stämmler, Frank, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tgbsh7mn30ibpnhnptptt6sv63